A promising technology for wound healing; in-vitro and in-vivo evaluation of chitosan nano-biocomposite films containing gentamicin

J Microencapsul. 2021 Mar;38(2):100-107. doi: 10.1080/02652048.2020.1851789. Epub 2020 Dec 15.

Abstract

Aim: This paper aims to study in-vitro and in-vivo evaluation of chitosan (CHI) biocomposite of gentamicin nanoparticles (GNPs) for wound healing. Methods: In this study, CHI nanoparticles (NPs) were prepared using the ionic gelation technique. GNP biocomposites were examined on the excision wound model in Wistar rats to determine the in-vivo efficiency. Results: The diameter and zeta potential of NPs were between 151-212.9 nm and 37.2 - 51.1 mV, respectively. The entrapment efficiency was in an acceptable range of 36.6-42.7% w/w. The release test information was fitted to mathematical models (Zero, First order, Higuchi, and Korsmeyer-Peppas), and according to calculations, the kinetics of drug release followed the Korsmeyer-Peppas model. A comparison of thermograms revealed that the drug was present in the formulation in a non-crystalline form. Conclusion: Histological studies of the wound showed that the rate of skin tissue repair was higher in the GNP biocomposite treatment group than in the others.

Keywords: Biocomposite; chitosan; gentamicin; ionic gelation; wound-healing.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / therapeutic use
  • Chitosan / chemistry*
  • Drug Carriers / chemistry*
  • Drug Liberation
  • Gentamicins / administration & dosage*
  • Gentamicins / chemistry
  • Gentamicins / therapeutic use
  • Nanoparticles / chemistry*
  • Rats
  • Rats, Wistar
  • Skin / drug effects
  • Skin / injuries
  • Skin / pathology
  • Wound Healing / drug effects*

Substances

  • Anti-Bacterial Agents
  • Drug Carriers
  • Gentamicins
  • Chitosan